Direct-to-Consumer Testing Industry: Global Markets

Report Highlights

The global market for direct-to-consumer (DTC) testing is estimated to increase from $1.6 billion in 2023 to reach $3.2 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.

Report Includes

• 21 data tables and 42 additional tables
• Analysis of the global market landscape of direct-to-consumer (DTC) testing industry
• Analyses of the global market trends, with market revenue data for 2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2029
• Estimate of the current market size and revenue prospects, along with a market share analysis by test type, application, distribution channel and region
• Facts and figures pertaining to the market dynamics, current and emerging technologies, regulations, and the expected impact of macroeconomic factors
• An analysis of patents related to DTC
• Overview of sustainability trends and ESG developments in the industry, with a focus on consumer attitudes, companies’ ESG score rankings and their ESG practices
• An analysis of the industry structure, including companies’ market shares, M&A activity, and venture funding
• Company profiles of major players within the industry, including Ancestry, 23andMe Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Inc., and MyHeritage Ltd.

Report Scope

The current report provides detailed information about the direct-to-consumer (DTC) testing market. The report provides market projections for 2029 and market share for key market players. It details the market size of DTC testing based on test types, applications and distribution channels. Based on the test type, the DTC testing market is segmented into genetic DTC tests, biomarker-based DTC tests and microbiome DTC tests. The report excludes at-home pregnancy tests, fertility tests and COVID-19 tests. Provider-dependent at-home tests also are not included in this report. The report is segmented into health and wellness testing, ancestry and genealogy testing, carrier screening, disease risk assessment, pharmacogenetic testing, whole genome sequence-based DTC testing and other DTC tests based on application. Based on the distribution channel, the market is categorized into online and retail.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Consulting Editor’s Credentials

Dr. Marianna Tcherpakov has more than 10 years of experience as a bench scientist specializing in the areas of biochemistry, cell biology, assay development, antibody and drug manufacturing. She has authored several scientific publications in peer review journals. In the last 10 years, Marianna worked as a business development professional in CRO/CDMO industry. She is familiar with pharmaceutical and biotech landscape, trends and potential future developments in industry.